Alessio Cerquaglia1,2, Christine Fardeau1, Carlo Cagini2, Tito Fiore2, Phuc LeHoang1. 1. a Ophthalmology Department, Reference Center in Rare Diseases , DHU Sight Restore , Hôpital Pitié Salpêtrière, University Paris VI, Paris , France. 2. b Department of Biomedical and Surgical Sciences, Section of Ophthalmology , University of Perugia , S. Maria della Misericordia Hospital, Perugia , Italy.
Abstract
PURPOSE: To describe the importance of a customized combined systemic and local therapy in the management of inflammatory choroidal neovascularization (iCNV). METHODS: Observational retrospective case series. RESULTS: Four iCNV cases, complicating posterior uveitis or panuveitis affecting young patients, are reported. Combination of both intravitreal (IVT) and systemic drugs represented a successful treatment strategy. CONCLUSIONS: iCNV is a sight-threatening disease which affects mostly young people. Customized and both systemic and IVT therapies might represent the best therapeutic option in order to obtain disease control and good prognosis.
PURPOSE: To describe the importance of a customized combined systemic and local therapy in the management of inflammatory choroidal neovascularization (iCNV). METHODS: Observational retrospective case series. RESULTS: Four iCNV cases, complicating posterior uveitis or panuveitis affecting young patients, are reported. Combination of both intravitreal (IVT) and systemic drugs represented a successful treatment strategy. CONCLUSIONS: iCNV is a sight-threatening disease which affects mostly young people. Customized and both systemic and IVT therapies might represent the best therapeutic option in order to obtain disease control and good prognosis.